Abstract
Objective To evaluate the strength and certainty of the evidence underlying an association between increased adiposity, as assessed by body-mass index (BMI), waist circumference (WC), or waist-to-hip ratio (WHR) and identify the risk of incident cardiovascular disease (CVD) events or mortality
Design Umbrella review of systematic reviews and meta-analyses.
Data sources Google Scholar, PubMed, Embase, Cochrane Database of Systematic Reviews, and manual screening of retrieved references
Eligibility criteria Systematic reviews or meta-analyses of observational studies and Mendelian randomisation (MR) studies that evaluated the association between various obesity-related indices and the risk of developing CVD and/or mortality due to CVD
Data synthesis Eleven systematic reviews and 53 meta-analyses that investigated associations between obesity and cardiovascular outcomes were included. Results from recently published cohort studies were also incorporated into the existing meta-analyses to update them with more recent data. Thus, the present study compiled all the relevant evidence accumulated to date, encompassing a total of 488 cohorts and over 30 million participants. MR studies were collected to identify any causal relationship between obesity and various CVD outcomes, and to avoid reverse causality. The degree of obesity was measured with BMI, WC, and WHR. The evidence levels of pooled results were graded into high, moderate, low, and very low according to the Grading of Recommendations Assessment, Development and Evaluation framework.
Results An increase in BMI was associated with a higher risk of developing coronary heart disease, heart failure, atrial fibrillation, stroke, hypertension, aortic valve stenosis, pulmonary embolism, and venous thromboembolism; the study results corroborate the casual effect of obesity on the incidence of CVD, except stroke, based on MR studies. The increase in the risk of developing CVD for every 5 kg/m2 increase in BMI ranged from 7% (relative risk [RR], 1.07; 95% confidence interval [CI], 1.03 to 1.11) for stroke to 49% (RR, 1.49; 95% CI, 1.41 to 1.58) for hypertension. The risk of all-cause mortality and CVD-specific mortality increased with adiposity, which was supported by a high grade of evidence from observational analyses; however, the causal effect of obesity on mortality outcomes was not significant in MR studies.
Conclusions Only 15 out of the 53 associations (28%) reported for obesity and CVD outcomes were supported with high evidence levels from observational analyses. Although other reported associations might be valid, various degrees of uncertainty remain. The causal effect of obesity on 9 of the 14 CVD-related outcomes was corroborated by MR studies. As obesity is progressively increasing around the globe and because CVD remains a constant threat to public health, it is necessary to understand the gradient of evidence underlying the association between these two clinical entities. Any weak links in the association and causality discovered in this review should be reinforced with further scientific research, while high-certainty associations with established causality should be reflected in clinical practices and health policies.
Systematic review registration PROSPERO CRD42020179469.
Section 1 What is already known on this topic
- Obesity is progressively increasing worldwide and cardiovascular disease (CVD) remains a continued threat to public health.
- Although obesity as a risk factor for various cardiovascular outcomes has been studied for decades, the results from previous studies are heterogeneous, making it difficult for clinicians and policy makers to determine genuine and reliable associations.
- The level of evidence underlying the associations between obesity and CVD remains unknown.
Section 2: What this study adds
- Only 15 of the 53 reported associations (28%) between obesity and CVD outcomes are supported with a high level of evidence. While other associations may be genuine, various degrees of uncertainty remain.
- An increase in body-mass index was associated with a higher risk of developing coronary heart disease, heart failure, atrial fibrillation, stroke, hypertension, aortic valve stenosis, pulmonary embolism, and venous thromboembolism; the casual effect of obesity on the incidence of CVD was corroborated by Mendelian randomisation (MR) studies, with the exception of stroke.
- The increase in the risk of all-cause mortality and CVD-specific mortality with adiposity was supported by a high grade of evidence in observational analyses, but the causal effect of obesity on mortality outcomes was not significant in MR studies.
Competing Interest Statement
The authors have declared no competing interest.
Clinical Trial
PROSPERO CRD42020179469.
Funding Statement
This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MSIT) (No. 2019R1A2C4070496).
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
NOT applicable. This is systematic review and meta-analysis.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Category: Umbrella review of systematic reviews and meta-analyses
This manuscript has been reviewed and approved by all authors. Min Seo Kim, Won Jun Kim, Amit V Khera, and Hong-Hee Won have no commercial associations that may present a conflict of interest in relation to this manuscript.
Data Availability
Not applicable